PegBio Co., Ltd. (HKG:2565)
Hong Kong · Delayed Price · Currency is HKD 5.36
-0.09 (-1.65%)
Jul 31, 2026, 4:08 PM HKT
PegBio Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 467.54 | 28.39 | 77.15 | 773.13 | 33.77 |
Trading Asset Securities | 54.47 | 153.66 | 263.08 | 84.57 | 23.37 |
Cash & Short-Term Investments | 522.01 | 182.05 | 340.23 | 857.7 | 57.14 |
Cash Growth | 186.75% | -46.49% | -60.33% | 1401.02% | 24.25% |
Other Receivables | 0.71 | 3.36 | 0.05 | 0.01 | - |
Receivables | 0.71 | 3.36 | 0.05 | 0.01 | - |
Inventory | 0.87 | - | - | 5.35 | 11.48 |
Other Current Assets | 32.69 | 4.89 | 5.2 | 25.59 | 7.49 |
Total Current Assets | 556.28 | 190.29 | 345.48 | 888.66 | 76.11 |
Property, Plant & Equipment | 15.27 | 5.1 | 6.95 | 3.09 | 3.45 |
Other Intangible Assets | 0.55 | 0.86 | 0.98 | 0.17 | 0.24 |
Long-Term Deferred Charges | - | - | - | 3.32 | 4.57 |
Other Long-Term Assets | 27.13 | 22.1 | 14.65 | 15.07 | 9.15 |
Total Assets | 599.23 | 218.36 | 368.05 | 910.32 | 93.52 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Accounts Payable | 25.24 | 35.12 | 90.61 | 23.48 | 67.78 |
Accrued Expenses | 24.91 | 3.96 | 6.34 | 5.45 | 2.26 |
Short-Term Debt | 84.97 | 100 | 65.78 | 110.14 | 35.05 |
Current Portion of Leases | 2.05 | 1.27 | 1.42 | - | - |
Current Income Taxes Payable | 0.95 | 0.43 | 0.81 | - | - |
Other Current Liabilities | 2.94 | 16.88 | 0.03 | 1.19 | 79.09 |
Total Current Liabilities | 141.06 | 157.67 | 164.99 | 140.27 | 184.18 |
Long-Term Leases | 6.59 | 0.22 | 1.71 | - | - |
Long-Term Unearned Revenue | 3 | 3 | 6 | 15.65 | 15.76 |
Total Liabilities | 150.64 | 160.89 | 172.7 | 155.92 | 199.94 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Common Stock | 391.09 | 366.67 | 366.67 | 354.51 | 254.22 |
Additional Paid-In Capital | - | - | - | 445.91 | 166.8 |
Retained Earnings | -1,343 | -1,134 | -851.1 | -52.3 | -534.94 |
Comprehensive Income & Other | 1,400 | 819.77 | 674.31 | - | - |
Total Common Equity | 448.49 | 52.19 | 189.88 | 748.12 | -113.92 |
Minority Interest | 0.1 | 5.28 | 5.47 | 6.28 | 7.5 |
Shareholders' Equity | 448.59 | 57.47 | 195.35 | 754.39 | -106.42 |
Total Liabilities & Equity | 599.23 | 218.36 | 368.05 | 910.32 | 93.52 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Total Debt | 93.61 | 101.49 | 68.91 | 110.14 | 35.05 |
Net Cash (Debt) | 428.41 | 80.55 | 271.32 | 747.56 | 22.09 |
Net Cash Growth | 431.83% | -70.31% | -63.71% | 3284.57% | 5.23% |
Net Cash Per Share | 1.13 | 0.22 | 0.75 | 2.81 | - |
Filing Date Shares Outstanding | 391.09 | 385.96 | 361.61 | 354.51 | - |
Total Common Shares Outstanding | 391.09 | 366.67 | 361.61 | 354.51 | - |
Working Capital | 415.23 | 32.63 | 180.49 | 748.39 | -108.07 |
Book Value Per Share | 1.15 | 0.14 | 0.53 | 2.11 | - |
Tangible Book Value | 447.93 | 51.33 | 188.91 | 747.94 | -114.16 |
Tangible Book Value Per Share | 1.15 | 0.14 | 0.52 | 2.11 | - |
Machinery | 12.42 | 12.41 | 12.32 | 8.71 | 8.22 |
Leasehold Improvements | 10.41 | 6.24 | 6.24 | - | - |